Autonomix Medical, Inc. Common StockAMIXNASDAQ
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank0
Studio
Year-over-Year Change

Year-over-year research & development expense growth

Percentile
P0
Near historical low
vs 3Y Ago
-0.1x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
PeriodValue
Q4 2025-27.17%
Q3 202548.59%
Q2 20252.58%
Q1 202548.75%
Q4 2024-11.07%
Q3 202423.06%
Q2 202436.68%
Q1 20241.60%
Q4 202345.86%
Q3 202327.99%
Q2 2023-9.58%
Q1 2023104.52%
Q4 2022188.01%
Q3 20220.00%
Q2 20220.00%